“Predictive Value of TGF-β1 and SMAD-7 Expression at Diagnosis for Treatment Response in Low-Risk Myelodysplastic Syndrome”. 2025. Biomolecules and Biomedicine 25 (5): 1175–1183. https://doi.org/10.17305/bb.2025.11564.